These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7777138)

  • 1. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease.
    Hatzinger M; Z'Brun A; Hemmeter U; Seifritz E; Baumann F; Holsboer-Trachsler E; Heuser IJ
    Neurobiol Aging; 1995; 16(2):205-9. PubMed ID: 7777138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
    Heuser I; Yassouridis A; Holsboer F
    J Psychiatr Res; 1994; 28(4):341-56. PubMed ID: 7877114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A; Arloth J; Best J; Namendorf C; Gerlach T; Czamara D; Lucae S; Dunlop BW; Crowe TM; Garlow SJ; Nemeroff CB; Ritchie JC; Craighead WE; Mayberg HS; Rex-Haffner M; Binder EB; Uhr M
    Psychoneuroendocrinology; 2016 Jul; 69():161-71. PubMed ID: 27107207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L
    ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender.
    Heuser IJ; Gotthardt U; Schweiger U; Schmider J; Lammers CH; Dettling M; Holsboer F
    Neurobiol Aging; 1994; 15(2):227-31. PubMed ID: 7838296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH; Siegrist J; Schuhmacher A; Hoefels S; Maier W; Zobel AW
    Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease.
    Heuser IJ; Chase TN; Mouradian MM
    Biol Psychiatry; 1991 Nov; 30(9):943-52. PubMed ID: 1660734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.